[Mediterranean visceral leishmaniasis during leukemic remission]. 1980

D Hauteville, and A Chagnon, and G Camilleri, and N Herne, and M Verdier

UI MeSH Term Description Entries
D007898 Leishmaniasis, Visceral A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. Black Fever,Kala-Azar,Fever, Black,Kala Azar,Visceral Leishmaniasis
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008297 Male Males
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

D Hauteville, and A Chagnon, and G Camilleri, and N Herne, and M Verdier
May 1990, Presse medicale (Paris, France : 1983),
D Hauteville, and A Chagnon, and G Camilleri, and N Herne, and M Verdier
April 1981, La Nouvelle presse medicale,
D Hauteville, and A Chagnon, and G Camilleri, and N Herne, and M Verdier
January 2011, Bulletin de l'Academie nationale de medecine,
D Hauteville, and A Chagnon, and G Camilleri, and N Herne, and M Verdier
January 1999, Presse medicale (Paris, France : 1983),
D Hauteville, and A Chagnon, and G Camilleri, and N Herne, and M Verdier
March 2003, Le infezioni in medicina,
D Hauteville, and A Chagnon, and G Camilleri, and N Herne, and M Verdier
January 1994, Scandinavian journal of infectious diseases,
D Hauteville, and A Chagnon, and G Camilleri, and N Herne, and M Verdier
January 1995, Bulletin of the World Health Organization,
D Hauteville, and A Chagnon, and G Camilleri, and N Herne, and M Verdier
April 1976, The Journal of tropical medicine and hygiene,
D Hauteville, and A Chagnon, and G Camilleri, and N Herne, and M Verdier
March 2018, European journal of rheumatology,
D Hauteville, and A Chagnon, and G Camilleri, and N Herne, and M Verdier
December 1981, Therapie der Gegenwart,
Copied contents to your clipboard!